PolyNovo Limited (CALZF)
CALZF Stock Price Chart
Explore PolyNovo Limited interactive price chart. Choose custom timeframes to analyze CALZF price movements and trends.
CALZF Company Profile
Discover essential business fundamentals and corporate details for PolyNovo Limited (CALZF) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Devices
IPO Date
8 Jan 2021
Employees
282.00
Website
https://polynovo.comCEO
Robyn Elliott BSc
Description
PolyNovo Limited develops medical devices in the United States, Australia, New Zealand, the United Kingdom, Ireland, Singapore, and internationally. The company offers NovoSorb Biodegradable Temporising Matrix, which is used in a fully debrided clean surgical wound to physiologically close the wound. It is also developing hernia devices for hernia repair and tissue reinforcement products; NovoSorb Dermal Beta Cell Implant to host pancreatic islets in the skin; and NovoSorb drug elution depots. The company was formerly known as Calzada Limited and changed its name to PolyNovo Limited in November 2014. PolyNovo Limited was incorporated in 1998 and is headquartered in Port Melbourne, Australia.
CALZF Financial Timeline
Browse a chronological timeline of PolyNovo Limited corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 23 Feb 2026
Earnings released on 25 Aug 2025
EPS came in at $0.00 matching the estimated $0.00, while revenue for the quarter reached $45.57M , meeting expectations.
Earnings released on 25 Feb 2025
EPS came in at $0.00 surpassing the estimated $0.00 by +6.12%, while revenue for the quarter reached $36.85M , missing expectations by -0.57%.
Earnings released on 22 Aug 2024
EPS came in at $0.00 falling short of the estimated $0.00 by -26.73%, while revenue for the quarter reached $37.37M , missing expectations by -0.79%.
Earnings released on 8 May 2024
EPS came in at $0.00 , while revenue for the quarter reached $32.10M , missing expectations by -3.11%.
Earnings released on 30 Jun 2023
EPS came in at -$0.00 surpassing the estimated -$0.01 by +84.08%, while revenue for the quarter reached $23.82M , beating expectations by +27.76%.
Earnings released on 31 Dec 2022
EPS came in at -$0.00 falling short of the estimated $0.00 by -388.97%, while revenue for the quarter reached $20.07M , missing expectations by -0.16%.
Earnings released on 30 Jun 2022
EPS came in at -$0.00 falling short of the estimated -$0.00 by -323.19%, while revenue for the quarter reached $16.05M , missing expectations by -0.18%.
Earnings released on 31 Dec 2021
EPS came in at $0.00 surpassing the estimated -$0.00 by +161.03%, while revenue for the quarter reached $13.12M , beating expectations by +0.23%.
Earnings released on 30 Jun 2021
EPS came in at -$0.00 falling short of the estimated -$0.00 by -61.33%, while revenue for the quarter reached $12.43M , missing expectations by -3.47%.
Earnings released on 31 Dec 2020
EPS came in at -$0.00 falling short of the estimated -$0.00 by -32.69%, while revenue for the quarter reached $9.67M , missing expectations by -12.10%.
CALZF Stock Performance
Access detailed CALZF performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.